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Summary
Background Long-term exposure to outdoor air pollution increases the risk of cardiovascular disease, but evidence is 
unclear on the health effects of exposure to pollutant concentrations lower than current EU and US standards and 
WHO guideline limits. Within the multicentre study Effects of Low-Level Air Pollution: A Study in Europe (ELAPSE), 
we investigated the associations of long-term exposures to fine particulate matter (PM2·5), nitrogen dioxide (NO2), 
black carbon, and warm-season ozone (O3) with the incidence of stroke and acute coronary heart disease.
Methods We did a pooled analysis of individual data from six population-based cohort studies within ELAPSE, from 
Sweden, Denmark, the Netherlands, and Germany (recruited 1992–2004), and harmonised individual and area-level 
variables between cohorts. Participants (all adults) were followed up until migration from the study area, death, or 
incident stroke or coronary heart disease, or end of follow-up (2011–15). Mean 2010 air pollution concentrations from 
centrally developed European-wide land use regression models were assigned to participants’ baseline residential 
addresses. We used Cox proportional hazards models with increasing levels of covariate adjustment to investigate the 
association of air pollution exposure with incidence of stroke and coronary heart disease. We assessed the shape of 
the concentration-response function and did subset analyses of participants living at pollutant concentrations lower 
than predefined values.
Findings From the pooled ELAPSE cohorts, data on 137 148 participants were analysed in our fully adjusted model. 
During a median follow-up of 17·2 years (IQR 13·8–19·5), we observed 6950 incident events of stroke and 10 071 incident 
events of coronary heart disease. Incidence of stroke was associated with PM2·5 (hazard ratio 1·10 [95% CI 1·01–1·21] 
per 5 μg/m³ increase), NO2 (1·08 [1·04–1·12] per 10 µg/m³ increase), and black carbon (1·06 [1·02–1·10] per 0·5 10–⁵/m 
increase), whereas coronary heart disease incidence was only associated with NO2 (1·04 [1·01–1·07]). Warm-season O3 
was not associated with an increase in either outcome. Concentration-response curves indicated no evidence of a 
threshold below which air pollutant concentrations are not harmful for cardiovascular health. Effect estimates for PM2·5 
and NO2 remained elevated even when restricting analyses to participants exposed to pollutant concentrations lower 
than the EU limit values of 25 µg/m³ for PM2·5 and 40 µg/m³ for NO2.
Interpretation Long-term air pollution exposure was associated with incidence of stroke and coronary heart disease, 
even at pollutant concentrations lower than current limit values.
Funding Health Effects Institute.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Ambient air pollution has decreased in recent decades in 
Europe and North America, but epidemiological studies in 
Australia, Canada, and the USA have suggested adverse 
health effects even at very low concentrations of pollution.1–7 
However, most of these studies investigated mortality and 
less evidence is available for incident disease.8–12 According 
to WHO, cardiovascular disease is the leading cause of 
death worldwide and accountable for a large share of 
morbidity and health-care costs.13 Thus, assessing the 
specific air pollution-related health burden of cardio-
vascular disease is crucial to inform policy makers. Such 
an assessment is especially important in view of upcoming 
revisions to the air quality directive in Europe,14 the 
US national ambient air quality standard for particulate 
matter (PM)15 and the WHO air quality guidelines.
Of all types of cardiovascular disease, coronary heart 
disease and stroke constitute the most frequent 
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diagnoses. Air pollution has been implicated in multiple 
biological mechanisms including systemic inflammation, 
oxidative stress, and autonomic nervous system 
imbalance affecting the cardiovascular system and the 
development of atherosclerosis,16,17 all of which are known 
disease mechanisms leading to coronary heart disease or 
stroke. Several epidemiological cohort studies have 
reported associations of cardiovascular disease incidence 
or mortality with long-term exposure to outdoor air 
pollution.9,11,18–22 Although most evidence is available for 
fine PM (PM2·5), uncertainty remains about the shape of 
the concentration-response function, particularly in the 
low-level exposure range. Several studies have suggested 
a steep slope in the lower range,5,6,11 whereas others have 
reported a linear increase.6,9 Only a few studies have 
evaluated the long-term effects of other regulated 
pollutants such as nitrogen dioxide (NO2) and ozone (O3), 
and of non-regulated pollutants such as black carbon (an 
indicator of soot).8–11,19–21,23
In the multicentre project Effects of Low-level Air 
Pollution: a Study in Europe (ELAPSE), we built on 
previous work of the European Study of Cohorts for Air 
Pollution Effects (ESCAPE),20,21 by pooling data of several 
existing cohort studies representing the lower range of 
air pollutant concentrations in Europe. Compared to the 
meta-analytical approach in ESCAPE, ELAPSE pooled 
and harmonised individual participant data, with a 
uniform exposure assessment via centrally developed 
European-wide air pollution maps,24 and included a 
prolonged follow-up period. These updates increased our 
power to detect associations and enabled an investigation 
of the concentration-response function at low levels of 
exposure.
The specific objective of this study was to investigate the 
association of long-term ambient air pollution exposure 
(to PM2·5, NO2, black carbon, and warm-season O3) and the 
incidence of stroke and acute coronary heart disease, with 
assessment of the shape of the concentration-response 
function at concentrations lower than current limit values 
set by the EU (PM2·5 25 µg/m³, NO2 40 µg/m³), the US 
Environmental Protection Agency (PM2·5 12 µg/m³), and 




We did a pooled analysis of individual data from 
six existing population-based cohort studies 
(12 sub cohorts) within ELAPSE. The cohorts enrolled 
adults from four northwestern European countries: 
Sweden (Cardiovascular Effects of Air Pollution and 
Noise in Stockholm [CEANS] study), Denmark (Diet, 
Cancer and Health [DCH] cohort and Danish Nurse 
Cohort [DNC]), the Netherlands (European Prospective 
Investigation into Cancer and Nutrition, the Netherlands 
[EPIC-NL]), and Germany (Heinz Nixdorf Recall [HNR] 
study and Cooperative Health Research in the Region of 
Augsburg [KORA]; appendix pp 2–9). Recruitment and 
baseline examinations took place between 1992 and 2004, 
and participants were followed up until migration or 
emigration from the study area, death, or incident stroke 
or coronary heart disease, or end of follow-up in 2011–15, 
whichever came first. All cohorts extracted and recoded 
their data according to a shared codebook for the ELAPSE 
project, and transferred their data to the Institute for 
Risk Assessment Sciences at Utrecht University (Utrecht, 
Research in context
Evidence before this study
We searched PubMed without language restrictions from 
database inception up to March 25, 2020, using the search 
terms “air pollution”, “long-term”, “incidence” and “stroke” or 
“cerebrovascular” or “ischemic“ or “ischaemic“ or “coronary” or 
“cardiovascular”. We then screened abstracts and full texts to 
select relevant articles. Our literature review showed that 
epidemiological evidence is inconsistent and scarce, especially 
for nitrogen dioxide (NO2), black carbon, and ozone (O3). 
Previous studies on low-level air pollution mainly focused on 
fine matter (PM2·5) and natural and cause-specific mortality, and 
studies on cardiovascular morbidity endpoints are rare. 
Furthermore, it remains unclear whether a potential threshold 
exists below which air pollutants are not harmful for 
cardiovascular health, as few studies have investigated the 
shape of the concentration-response function.
Added value of this study
This study provides the first European multicountry analysis, 
pooling data from six well characterised European cohorts to 
investigate whether long-term exposure to low 
concentrations of outdoor air pollution affects the incidence 
of cardiovascular events. In addition to PM2·5, for which some 
evidence is already available from Canada and the USA, 
we also assessed the regulated pollutants NO2 and O3, 
and non-regulated black carbon as an indicator for soot, all of 
which were modelled centrally for western Europe. Exposure 
concentrations of PM2·5, NO2, and black carbon had significant 
associations with stroke, and for NO2, with coronary heart 
disease, even after adjustment for road traffic noise. 
Importantly, we provide novel insights into the shape of the 
concentration-response function, which did not show 
evidence for threshold effects.
Implications of all the available evidence
Our study provides evidence on the positive association 
between long-term exposure to ambient air pollution and 
cardiovascular events at concentrations lower than the existing 
EU and WHO guideline limits. Our findings are consistent with 
previous studies and are of major importance, as they imply 
that populations might benefit from a lowering of 
concentrations of PM2·5, NO2, and black carbon in Europe.
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Netherlands), where the data were checked, pooled, and 
stored on a secure server. For the purposes of this 
analysis, participants with their residential address 
missing at baseline were excluded. The present analysis 
and wider ELAPSE project was done in accordance with 
the Declaration of Helsinki. The original cohort studies 
were approved by the relevant authorities complying 
with all relevant national, state, and local regulations, 
and written informed consent was obtained from all 
participants before enrolment.
Outcome definitions
We analysed incident events of stroke and coronary heart 
disease that occurred during follow-up. Events were 
derived by record-linkage of hospital discharge and 
mortality registries for all cohorts except those from 
Germany. Stroke was defined according to the criteria 
of relevant International Classification of Diseases 
(ICD) codes, comprising hospitalisation with principal 
diagnosis of ischaemic, haemorrhagic, or unspecified 
stroke, and out-of-hospital deaths from cerebrovascular 
diseases. Acute coronary heart disease was defined 
(per ICD codes) as hospitalisation with a principal 
diagnosis of acute myocardial infarction or other acute or 
subacute forms of coronary heart disease, or out-of-
hospital death from coronary heart disease. The specific 
ICD codes are provided in the appendix (p 10). 
For the German cohorts, outcome identification was 
accomplished by interview and inspection of medical 
records and death certificates. To derive incident events, 
we excluded participants with a history of either stroke or 
coronary heart disease at least 3 years before enrolment.
Exposure assessment
Annual mean concentrations of PM2·5, NO2, black carbon, 
and warm-season O3 (from April to September inclusive) 
were centrally modelled for western Europe for the 
year 2010 by land use regression (LUR) models.24 We 
regressed routine monitoring data from the AirBase 
network of the European Environmental Agency (PM2·5, 
NO2, and O3) or measurements from ESCAPE monitoring 
sites (black carbon) on satellite observations, chemical 
transport model estimates, land use, and road data 
(appendix p 11). Models were validated with 5-fold cross-
validation; all models performed well with an R² value (ie, 
spatial variability of the measured concentrations that can 
be explained by the model) of 66% for PM2·5, 58% for NO2, 
51% for black carbon, and 60% for O3. We then applied the 
models to 100 m grids to produce concentration surfaces 
and assigned the respective exposures of these grids 
to the residential addresses of our cohort participants 
at recruitment, as spatial variation of the pollutant con-
centrations has been shown to be reasonably stable during 
periods of about 10 years (appendix p 12). In addition, we 
estimated pollutant concentrations for each year from 
recruitment to end of follow-up via back-extrapolation 
using both the absolute difference and the ratio between 
annual average concentrations and 2010 exposures from 
our main model, and assigned these concentrations to 
participant addresses during follow-up when available 
(appendix p 12). Spearman correlation coefficients were 
calculated separately for each subcohort to assess and 
compare correlations between air pollutants.
Statistical analysis
We used Cox proportional hazards models with age as an 
underlying time variable, following each cohort member 
from start of follow-up to time of first occurrence of 
stroke or coronary heart disease, or censoring at the date 
of death, migration, loss to follow-up, or end of 
follow-up. We stratified models by subcohort, thus 
allowing the baseline hazard to vary by subcohort, 
to address heterogeneity of participant characteristics 
and outcome diagnosis coding across cohorts.26 We 
specified a priori three models with increasing strengths 
of confounder adjustment on the basis of previous 
studies20,21 and availability of data in the participating 
cohorts. Model 1 included age (time scale, in years), sex 
and subcohort (both as strata variables), and the cohort 
baseline year. Model 2 further adjusted for individual 
lifestyle and socioeconomic information at baseline: 
marital status (single, married or living with partner, 
divorced or separated, or widowed), body-mass index 
(BMI; following the WHO categorisation of underweight 
[<18·5 kg/m²], normal weight [18·5–24·9 kg/m²], 
overweight [25·0–29·9 kg/m²], and obese [≥30·0 kg/m²]), 
smoking status (never, former, or current) and smoking 
duration (years), intensity of smoking among current 
and former smokers (cigarettes per day) and smoking 
intensity squared, employment status (yes or no), and 
education level (primary or less, secondary, or tertiary, as 
per country-specific definitions). Model 3 additionally 
included neighbourhood-level socioeconomic status 
(mean income in 2001)27. The spatial scale of neigh-
bourhoods varied from small neighbourhoods and city 
districts (in the CEANS, EPIC-NL, and HNR studies) to 
municipalities (in the DCH, DNC, and KORA studies). 
Participants with missing information in model 3 
covariates were excluded from most analyses, although 
to examine potential selection bias, we also ran model 1 
and model 2 with the eligible populations for each 
model. Each pollutant was first included separately as a 
linear term. To assess the shape of the concentration-
response function, we applied natural cubic splines with 
three degrees of freedom and a 2016 modelling frame-
work called the shape-constrained health impact function 
(SCHIF; appendix p 17).28 We investigated if associations 
persisted at low concentrations by excluding participants 
living at concentrations higher than a priori defined 
cutoff values, which were partly based on existing EU 
and US limit values and WHO guidelines (cutoff values 
in the ranges 10–25 µg/m³ for PM2·5 and 20–40 µg/m³ for 
NO2) and expected ranges (0·5–3·0 10–⁵/m for black 
carbon and 60–100 µg/m³ for warm-season O3). Black 
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carbon was measured by the reflectance of PM2.5 filters 
and expressed in absorbance units. We further used two-
pollutant models to test the independence of the pollutant 
effect estimates. Hazard ratios (HRs) and 95% CIs 
(calculated with a normal approximation) are presented 
for fixed increments in each exposure (approximately the 
IQR after rounding), defined a priori to cover the range 
in concentrations within the different cohorts while 
maintaining increments broadly comparable between 
pollutants in terms of variability.
In sensitivity analyses, we examined the robustness of 
findings by reiterating the main linear model with 
either annual mean concentrations back-extrapolated to 
the year of baseline examination, or time-varying 
concentrations linking back-extrapolated annual mean 
concentrations per year to each participant address from 
baseline to an incident event or censoring for those 
cohorts with complete residential history (CEANS, DCH, 
and EPIC-NL). For the second approach, we incorporated 
1-year or 5-year strata of follow-up time in the Cox model 
to account for time trends in incidence (appendix p 18). In 
addition, we inspected natural splines with three degrees 
of freedom in time-varying analysis (with the ratio back-
extrapolation and 1-year strata to adjust for time trends) to 
test the sensitivity of our findings with respect to the 
strength of associations. Because traffic noise has been 
reported as an important environmental risk factor for 
cardiovascular disease,22,29 we additionally adjusted for 
locally assessed road traffic noise at the baseline address 
(appendix p 19). Furthermore, since air pollution has also 
been related to obesity30,31 and, therefore, BMI might be a 
factor in the causal pathway from air pollution to 
cardiovascular disease, we excluded BMI from the main 
adjustment set in model 3 to examine potential 
overadjustment. We also did stratified analyses by 
subcohort with subsequent pooling of cohort-specific 
effect estimates using random-effects meta-analyses with 
the DerSimonian and Laird method.32
We evaluated violation of the proportional hazards 
assumption of the Cox models for all covariates by 
investigating the scaled Schoenfeld residuals against 
time, and applying the global test from the R survival 
package. All statistical analyses were done in R, 
version 3.4.0, according to centrally developed analysis 
scripts run via secure remote access to the Utrecht 
University server.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results
The pooled ELAPSE cohorts with available data on stroke 
or coronary heart disease provided information on 
157 265 participants, of whom 151 981 (96·6%) had 
complete air pollution exposure information (based on 
residential address at baseline) and no stroke or coronary 
heart disease diagnosis in the past three years (appendix 
pp 4–9, 20). After exclusion of participants with missing 
information on the main model 3 covariates (14 833 [9·8%]), 
ranging from 71 (1·6%) of 4446 in the HNR study, to 
1734 (46·3%) of 3747 in the KORA-S4 subcohort (for which 
neighbourhood mean income was not available for the city 
of study, Augsburg), a total of 137 148 participants 
contributing 2 168 806 person-years at risk were included 
in the main analyses (table 1). Of these participants, 
6950 had an incident event of stroke and 10 071 had an 
incident event of coronary heart disease during a median 
follow-up of 17·2 years (IQR 13·8–19·5). Cohorts were 
heterogeneous in terms of participant number and 
characteristics, and distribution of covariates. The mean 
age at baseline was 54 years (SD 5), 92 427 participants 
(67·4%) were women, 17 470 (12·7%) had obesity, and 
43 137 (31·5%) were current smokers (table 1). A map of 
the study areas and further details on individual cohort 
characteristics are provided in the appendix (pp 4–9, 20, 26).
Air pollution concentrations varied between studies 
and within the study areas of subcohorts (figure 1). All 
participants were exposed to PM2·5 concentrations 
markedly lower than the EU limit value of 25 µg/m³, and 
most participants in Sweden were at concentrations 
lower than the WHO guideline limit of 10 µg/m³. 
For NO2, 127 305 (92·8%) participants (ranging from all 
7488 participants in the CEANS-Stockholm Diabetes 
Prevention Program subcohort, to 3324 [76·0%] in the 
HNR study) resided in areas at concentrations lower than 
the EU limit value and WHO guideline limit of 40 µg/m³. 
The correlations (Spearman) between different pollutants 
were heterogeneous across subcohorts, although overall 
were positive for PM2·5, NO2, and black carbon, with the 
highest coefficients between NO2 and black carbon 
(0·64 to 0·93, except 0·38 in the CEANS-Swedish 
National Study on Aging and Care in Kungsholmen 
subcohort; appendix p 27), and mostly moderate 
correlations between PM2·5 and NO2 (0·20 to 0·75). 
Warm-season O3 mostly showed negative correlations 
with all other pollutants (eg, –0·85 to –0·15 for NO2).
In linear analyses, HR point estimates indicated 
positive associations for all pollutants with stroke or 
coronary heart disease incidence except warm-season O3 
(table 2). The magnitude of the associations decreased 
with stricter covariate adjustment, although most of the 
significant associations remained significant in our main 
model 3. Hazard ratios for the incidence of stroke and 
coronary heart disease per 10 μg/m³ increase in NO2 
were 1·08 (95% CI 1·04–1·12) and 1·04 (1·01–1·07), 
respectively, indicating significant associations. The 
reduction in HR was primarily due to adjustments for 
smoking when excluding each variable separately (data 
not shown). PM2·5 was significantly associated with 
incident events of stroke (HR 1·10 [1·01–1·21] per 5 μg/m³ 
increase) but not with coronary heart disease incidence 
(1·02 [0·95–1·10]). Black carbon was significantly 
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associated with stroke (1·06 [1·02–1·10]) per 0·5 10–⁵/m 
but not with coronary heart disease (1·02 [0·99–1·06]). 
Similar (sometimes identical) effect estimates were 
obtained from models 1 and 2 when analysing the main 
model 3 population or the eligible populations for those 
models, suggesting that low selection bias was introduced 
by excluding participants with missing covariates.
Our investigation of concentration-response relation-
ships with natural cubic splines suggested steeper slopes 
at low exposures versus high exposures with no evidence 
of a threshold (focusing on the 5th and 95th percentiles of 
the concentration distribution) for the association of 
PM2·5, NO2, and black carbon with stroke, and PM2·5 with 
coronary heart disease (figure 2). For NO2 and coronary 
heart disease, we found little evidence of an association at 
concentrations lower than 20 µg/m³. These findings were 
supported by the SCHIF model analysis, which showed 
slightly steeper slopes at low exposures for the association 
of PM2·5, NO2, and black carbon with stroke, an increase in 
slope at concentrations higher than 20 µg/m³ for NO2 and 
Figure 1: Residential air pollution exposure as 2010 annual mean concentrations
Vertical red lines indicate the limit values set by the EU (PM2·5 25 µg/m³, NO2 40 µg/m³), US Environmental Protection Agency (PM2·5 12 µg/m³), and WHO guidelines 
(PM2·5 10 µg/m³, NO2 40 µg/m³). Bold lines in the middle of the boxes indicate median values (50th percentiles); lower and upper hinges correspond to 25th and 
75th percentiles; lower and upper whiskers to 5th and 95th percentiles. CEANS=Cardiovascular Effects of Air Pollution and Noise in Stockholm study. 
SDPP=Stockholm Diabetes Prevention Program. SIXTY=the Stockholm 60 years old study. SALT=the Stockholm Screening Across the Lifespan Twin study and 
TwinGene study. SNAC-K=the Swedish National Study on Aging and Care in Kungsholmen. DCH=Diet, Cancer, and Health cohort. DNC=Danish Nurses Cohort. 
EPIC-NL=European Prospective Investigation into Cancer and Nutrition, the Netherlands. MORGEN= Monitoring Project on Risk Factors for Chronic Diseases. 
HNR=Heinz Nixdorf Recall study. KORA=Cooperative Health Research in the Augsburg Region. S3=Survey 3. S4=Survey 4. NO2=nitrogen dioxide. O3=ozone.
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coronary heart disease, and decreasing curves for warm-
season O3 (appendix p 28). Corresponding with the 
concentration-response curves, effect estimates were 
mostly unchanged or slightly increased in subset analyses 
at low air pollution concentrations (table 3), but the 
precision of the estimates decreased with smaller 
numbers of cohorts and participants remaining in the 
analysis at successively low cutoff concentrations (eg, for 
stroke, HR of 1·18 [95% CI 1·04–1·33] at <15 μg/m³ PM2·5 
and 1·12 [1·06–1·18] at <30 μg/m³ NO2).
In two-pollutant models, effect estimates for NO2 and 
black carbon were robust to PM2·5 adjustment, whereas 
PM2·5 estimates decreased on adjustment for NO2 and 
black carbon (appendix p 21). O3 was not robust to 
adjustment for NO2 resulting in a positive association, 
although non-significant, with stroke and a weakened, 
non-significant inverse association with coronary heart 
disease.
In our sensitivity analyses, effect estimates of air 
pollutants back-extrapolated to the year of baseline 
examination were similar to or slightly smaller than our 
main exposures, except for the association of PM2·5 
with stroke, for which the effect was almost halved 
(appendix p 22). Restriction to cohorts with complete 
residential history (CEANS, DCH, and EPIC-NL) had 
minimal effect on the results of the main model and time-
varying concentrations for this subset caused only slight 
differences in the magnitude of the HRs (appendix p 23). 
Time-varying exposure natural splines also indicated 
associations at low pollution concentrations, specifically 
for the association of NO2 and black carbon with stroke 
(appendix p 29). Noise was only moderately correlated 
with all air pollutants (positive correlations with PM2·5, 
NO2, and black carbon, negative correlations with O3; 
appendix p 27) and adjustment for noise did not affect the 
estimates except for PM2·5 in relation to stroke (slightly 
reduced effect estimate; appendix p 24). The exclusion of 
adjustment for BMI in model 3 resulted in almost 
identical estimates compared with those in our main 
linear model (appendix p 25). Stratified analysis by 
subcohort and subsequent meta-analysis indicated similar 
pooled estimates to those in our main model, with little 
evidence of heterogeneity (I²≤50% for all combinations 
and χ² p value ≥0·05 for all combinations except NO2 and 
coronary heart disease) in the cohort-specific estimates 
(appendix 30–31).
We detected deviation from the proportional hazards 
assumption for BMI and smoking status. A sensitivity 
analysis incorporating these in strata did not show results 
deviating from the main analysis (appendix p 32).
Discussion
In this pooled analysis of more than 130 000 participants 
from six European cohorts, we observed increased HRs 
for stroke incidence with long-term exposure to PM2·5, 
NO2, and black carbon. For coronary heart disease, we 
observed an increased HR with NO2 exposure only. 
Warm-season O3 exposure was not related to stroke or 
coronary heart disease. The concentration-response 
functions indicated no threshold values for these 
associations, and visible associations were maintained 
when restricting analyses to participants living at 
pollutant concentrations lower than the EU annual mean 
limits of 40 µg/m³ for NO2 and 25 µg/m³ for PM2·5, the 
US standard of 12 µg/m³ for PM2·5, and the WHO air 
quality guideline limit of 40 µg/m³ for NO2 and 10 µg/m³ 
for PM2·5.
Most evidence on low-level air pollution is available for 
PM2·5 and our results for stroke are generally in line with 
previous studies. A study in the USA11 on hospital 
Increment Main model 3 population Other model populations
Model 1* (n=137 148) Model 2† (n=137 148) Model 3‡ (n=137 148) Model 1* (n=151 981) Model 2† (n=141 965)
Stroke
PM2·5, µg/m³ 5 1·20 (1·09–1·31) 1·10 (1·01–1·21) 1·10 (1·01–1·21) 1·20 (1·10–1·31) 1·11 (1·02–1·22)
NO2, µg/m³ 10 1·10 (1·06–1·14) 1·07 (1·03–1·11) 1·08 (1·04–1·12) 1·11 (1·08–1·15) 1·08 (1·04–1·12)
Black carbon, 
10–⁵/m
0·5 1·09 (1·05–1·13) 1·06 (1·02–1·10) 1·06 (1·02–1·10) 1·10 (1·06–1·14) 1·07 (1·03–1·10)
Warm-season O3, 
µg/m³
10 0·90 (0·86–0·95) 0·96 (0·91–1·01) 0·96 (0·91–1·01) 0·89 (0·85–0·93) 0·95 (0·90–1·00)
Coronary heart disease
PM2·5, µg/m³ 5 1·09 (1·01–1·18) 1·02 (0·95–1·11) 1·02 (0·95–1·10) 1·10 (1·03–1·19) 1·02 (0·95–1·10)
NO2, µg/m³ 10 1·06 (1·03–1·09) 1·03 (1·00–1·06) 1·04 (1·01–1·07) 1·07 (1·04–1·10) 1·04 (1·01–1·07)
Black carbon, 
10–⁵/m
0·5 1·05 (1·01–1·08) 1·02 (0·99–1·05) 1·02 (0·99–1·06) 1·05 (1·02–1·08) 1·02 (0·99–1·05)
Warm-season O3, 
µg/m³
10 0·90 (0·86–0·93) 0·94 (0·90–0·98) 0·94 (0·90–0·98) 0·89 (0·86–0·93) 0·94 (0·90–0·98)
Models 1–3 provide increasing control for covariates (greatest in the main model 3 population). NO2=nitrogen dioxide. O3=ozone.*Model 1: adjusted for subcohort (strata), 
age (timescale), sex (strata), and year of baseline visit. †Model 2 further adjusted for marital status, body-mass index, smoking (status, duration, intensity, intensity squared), 
employment status, and education. ‡Model 3 further adjusted for 2001 mean income on a neighbourhood level.
Table 2: Hazard ratios and 95% CIs for linear associations between air pollution exposures and incidence of stroke or coronary heart disease
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Figure 2: Natural cubic splines 
for stroke (A) and coronary 
heart disease (B)
The solid line is at three 
degrees of freedom; red 
dashed lines show 95% CIs. 
The model adjusted for 
subcohort (strata), age 
(timescale), sex (strata), year 
of baseline visit, marital 
status, body-mass index, 
smoking (status, duration, 
intensity, intensity squared), 
employment status, 
education, and 
neighbourhood mean income. 
The bars are histograms 
(independent of the y axis) 
and indicate distribution of 
the air pollutant data, and 
dashed vertical lines the 5th 
and 95th percentiles. The HR is 
1 for minimum pollution 
exposure. HR=hazard ratio. 
NO2=nitrogen dioxide. 
O3=ozone.
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admissions among Medicare beneficiaries, a study combi-
ning two UK cohorts,10 and our previous study within the 
ESCAPE project21 with partly overlapping cohorts all 
indicated increased HRs for stroke in linear analyses. 
Two other large studies in the USA4 and Canada6 on stroke 
and cerebrovascular disease mortality reported slightly 
lower estimates compared with our results (table 4). 
Compared with our observations, all of these previous 
studies, and a large Canadian study9 on myo cardial 
infarction incidence, reported stronger asso ciations of 
PM2·5 exposure with coronary heart disease (incidence or 
mortality; HR ranging between 1·06–1·16, all estimates 
converted to a 5 µg/m³ increase). Most of these studies 
assessed the shape of the concentration-response functions 
with splines11, SCHIF modelling,6,9 or subset analyses,11,20,21 
with similar results to our study. The Medicare study11 
reported a steep slope of the concentration-response 
function in the low range, plateauing or slightly decreasing 
at PM2·5 concentrations higher than 12 µg/m³ (stroke) and 
14 µg/m³ (myocardial infarction), whereas our curves 
changed at about 15 µg/m³ (stroke) and 12 µg/m³ (coronary 
heart disease). The Canadian mortality study also reported 
a steep increase in the low range of PM2·5 exposure for 
coronary heart disease mortality, but a linear association 
with cerebrovascular disease mortality.6 A linear increase 
was also described by the Canadian study for myocardial 
infarction incidence.9 Interestingly, restricting analyses to 
observations with PM2·5 concen trations lower than the US 
standard of 12 μg/m³ in the Medicare study also increased 
the HRs. The HR values were 1·29 (95% CI 1·27–1·31) for 
stroke and 1·18 (1·16–1·21) for myocardial infarction,11 
compared with 1·18 (0·97–1·43) and 1·15 (0·88–1·50), 
respectively, in our subset analyses. Similarly, results of the 
meta-analysis in ESCAPE20,21 indicated increased HRs for 
the incidence of stroke and coronary heart disease when 
restricting analyses to participants living at PM2·5 
concentrations lower than the EU limit value of 25 μg/m³, 
but also 20 μg/m³ and 15 μg/m³. As a whole, our study 
results combined with previous studies provide consistent 
evidence to support associations between long-term PM2·5 
exposure with incident stroke at exposure concentrations 
lower than currently used or recommended limits. 
Cohorts Participants Participants with incident event Hazard ratio (95% CI)
Stroke Coronary heart disease Stroke incidence Coronary heart disease 
incidence
PM2·5, µg/m³
Full dataset 12 137 148 6950 10 071 1·10 (1·01–1·21) 1·02 (0·95–1·10)
<25 12 137 148 6950 10 071 1·10 (1·01–1·21) 1·02 (0·95–1·10)
<20 12 135 537 6904 9990 1·10 (1·01–1·21) 1·02 (0·94–1·10)
<15 12 85 498 5181 6607 1·20 (1·04–1·38) 1·06 (0·94–1·20)
<12 9 34 848 1690 2356 1·25 (0·90–1·72) 1·15 (0·88–1·50)
<10 7 20 241 799 1095 1·91 (0·60–1·38) 1·15 (0·80–1·65)
NO2, µg/m³
Full dataset 12 137 148 6950 10 071 1·08 (1·04–1·12) 1·04 (1·01–1·07)
<40 12 127 305 6603 9355 1·08 (1·04–1·13) 1·04 (1·00–1·07)
<30 12 79 157 4117 5662 1·17 (1·09–1·25) 1·01 (0·95–1·07)
<20 11 29 451 1255 2072 1·16 (0·97–1·40) 1·05 (0·92–1·21)
Black carbon, 10–⁵/m
Full dataset 12 137 148 6950 10 071 1·06 (1·02–1·10) 1·02 (0·99–1·06)
<3·0 12 137 114 6948 10 068 1·06 (1·02–1·10) 1·02 (0·99–1·06)
<2·5 12 136 696 6932 10 036 1·06 (1·02–1·10) 1·02 (0·99–1·05)
<2·0 12 128 825 6689 9536 1·06 (1·02–1·11) 1·02 (0·99–1·06)
<1·5 12 84 602 4497 6230 1·11 (1·04–1·19) 1·02 (0·97–1·08)
<1·0 8 34 153 1579 2382 1·17 (0·98–1·40) 0·88 (0·76–1·01)
<0·5 7 4844 117 230 1·73 (0·48–6·23) 0·76 (0·32–1·79)
Warm-season O3, µg/m³
Full dataset 12 137 148 6950 10 071 0·96 (0·91–1·01) 0·94 (0·90–0·98)
<100 12 137 148 6950 10 071 0·96 (0·91–1·01) 0·94 (0·90–0·98)
<80 12 89 251 4466 6548 0·98 (0·91–1·05) 0·93 (0·88–0·98)
<60 8 1602 23 125 0·29 (0·09–0·96) 1·64 (0·81–3·31)
Participants living at concentrations higher than the specified cutoff values were excluded. The model adjusted for subcohort (strata), age (timescale), sex (strata), year of 
baseline visit, marital status, body-mass index, smoking (status, duration, intensity, intensity squared), employment status, education, and neighbourhood mean income. 
Increments for the hazard ratio were 5 µg/m³ for PM2·5, 10 µg/m³ for NO2, 0·5 10–5/m for black carbon, and 10 µg/m³ for O3. HR=hazard ratio. NO2=nitrogen dioxide. O3=ozone.
Table 3: Subset analyses at low air pollution concentrations for associations with stroke and coronary heart disease incidence
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Concentration-response functions indicate no threshold 
for association at low concentrations. For stroke, our HR 
of 1·10 (1·01–1·21) per 5 µg/m³ increase in PM2·5 was 
slightly higher than that reported in a 2019 meta-analysis 
(1·07 [1·05–1·10] for Europe).18 Although our study does 
not confirm an association of PM2·5 with incident coronary 
heart disease, other studies provide evidence of this. In 
addition to the aforementioned studies of low-level 
exposure, other studies have provided substantial evidence 
supporting a positive association between PM2·5 and 
stroke18,33–38 or coronary heart disease.33,34,36–38
In contrast to our results, previous studies investigating 
long-term low-level NO2 exposure in relation to incident 
stroke or coronary heart disease have reported no 
association or only weak associations by linear modelling 
of exposure (table 4). For stroke, our concentration-
response function showed a steep increase up to about 
20 μg/m³. Consistently, when restricting our analyses to 
NO2 concentrations lower than 30 μg/m³ and 20 μg/m³, 
the HR showed slight increases, implicating the 
possibility of associations at concentrations less than half 
the current EU and WHO guideline limit (40 µg/m³). 
Region Outcome Participants Stroke Coronary heart disease
HR (95% CI)* Shape of concentration-
response function†
HR (95% CI)* Shape of concentration-response 
function†
PM2·5, µg/m³
ELAPSE (current study) Europe Incidence 137 148 1·10 (1·01–1·21) Increase up to ~15 μg/m³; 
plateau at higher 
concentrations
1·02 (0·95–1·10) Increase up to ~12 μg/m³; plateau 
at higher concentrations
Medicare members (Danesh 
Yazdi et al, 201911)
USA Incidence 11 084 660 ·· ·· ·· ··
Overall ·· ·· ·· 1·165 (1·159–1·171)† Increase between 
~7·5–12 μg/m³; plateau at 
concentrations higher than 
~12 μg/m³
1·137 (1·126–1·148)† Increase between ~7·5–14 μg/m³; 
decrease at concentrations higher 
than ~14 μg/m³
<12 μg/m³ ·· ·· ·· 1·29 (1·27–1·31) NA 1·18 (1·16–1·21) NA
ONPHEC (Bai et al, 20199) Canada Incidence 5 141 172 NA NA 1·07 (1·06–1·09) Linear increase
EPIC-Oxford, UK Biobank 
(Cai et al, 201810)
UK Incidence 289 128 1·14 (0·65–1·99) NA 1·06 (0·76–1·48) NA
ESCAPE (Cesaroni et al, 
2014;20 Stafoggia et al, 
201421)
Europe Incidence 111 931‡ ·· ·· ·· ··
Overall ·· ·· ·· 1·19 (0·88–1·62) NA 1·13 (0·98–1·30) NA
<25 μg/m³ ·· ·· ·· 1·29 (0·84–1·98) NA 1·18 (1·01–1·39) NA
<20 μg/m³ ·· ·· ·· 1·29 (1·00–1·68) NA 1·17 (0·91–1·50) NA
<15 μg/m³ ·· ·· ·· 1·24 (0·98–1·58) NA 1·19 (1·00–1·42) NA
NIH-AARP Diet and Health 
(Hayes et al, 20194)
USA Mortality 565 477 1·07 (1·01–1·13) NA 1·08 (1·04–1·11) NA
CANCHEC (Pinault et al, 
20176)
Canada Mortality 2 448 500 1·05 (1·00–1·11) Linear increase 1·16 (1·13–1·20) Steep increase up to ~7 µg/m³; 
increase at higher concentrations
NO2, µg/m³
ELAPSE (current study) Europe Incidence 137 148 1·08 (1·04–1·12) Steep increase up to 
~20 µg/m³; slight increase at 
higher concentrations
1·04 (1·01–1·07) Increase higher than ~20 µg/m³
ONPHEC (Bai et al, 20199) Canada Incidence 5 141 172 NA NA 1·004 (0·996–1·012)† Steep increase up to ~20 µg/m³; 
slight increase at higher 
concentrations
Oakland KPNC members 
(Alexeef et al, 20188)
USA Incidence 41 869 0·99 (0·83–1·18) Cardiovascular disease 
incidence only: increase with 
plateau at ~5–10 µg/m³
1·07 (0·92–1·24) Cardiovascular disease incidence 
only: increase with plateau at 
~5–10 µg/m³
HUNT2, EPIC-Oxford, UK 
Biobank (Cai et al, 201810)
Norway, 
UK
Incidence 355 732 1·03 (0·94–1·12) NA 0·98 (0·93–1·04) NA
ESCAPE (Cesaroni et al, 2014;20 
Stafoggia et al, 201421)
Europe Incidence 111 931‡ 0·99 (0·89–1·11) NA 1·03 (0·97–1·08) NA
HR=hazard ratio. ELAPSE=Effects of Low-Level Air Pollution: A Study in Europe. NA=not available. ONPHEC=Ontario Population Health Environment Cohort. EPIC-Oxford=European Prospective Investigation 
into Cancer and Nutrition-Oxford. ESCAPE=European Study of Cohorts for Air Pollution Effects. NIH–AARP=National Institutes of Health–American Association of Retired Persons. CANCHEC=Canadian Census 
Health and Environment Cohort. NO2=nitrogen dioxide. KPNC=Kaiser Permanente Northern California. HUNT=Helseundersøkelsen i NordTrøndelag. *All HRs were transformed to the ELAPSE increments of 
5 µg/m³ for PM2·5 and 10 µg/m³ for NO2. †Presented with three decimal places as two were not informative. ‡99 446 participants included in main analysis for stroke and 100 166 for coronary heart disease.
Table 4: Comparison with previous large studies on low-level air pollution and incidence of stroke and coronary heart disease (single-pollutant results)
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Additionally, the Canadian incidence study9 reported a 
positive slope in association with myocardial infarction 
that was steepest below 20 µg/m³. Several other studies 
on NO2 and incidence of cardiovascular disease have 
reported positive associations.22,34–36,39
In our analyses, NO2 associations were robust on 
adjustment for PM2·5 in two-pollutant models, whereas 
the HR for PM2·5 was reduced to approximately 1 for both 
outcomes. Because NO2 was moderately correlated with 
PM2·5 in most of our cohorts and the width of the 95% CIs 
increased only marginally in two-pollutant models, the 
reduction of the PM2·5 estimate is probably not an artifact 
of multicollinearity. The NO2 association might be related 
to direct NO2 effects or correlated combustion-related 
particles such as ultrafine particles or black carbon. Thus, 
the reduction of the PM2·5 HR does not imply that 
particles in our study are not associated with stroke or 
coronary heart disease, as adjustment for NO2 also 
adjusted for particles from the same sources shared with 
NO2, including motorised traffic and other combustion 
sources. Unlike in a large national study in Switzerland 
on myocardial infarction mortality,22 we found that NO2 
associations were also stable on adjustment for road 
traffic noise. The results of the ELAPSE project, therefore, 
strengthen the role of NO2 or correlated pollutants as a 
relevant risk factor for stroke and coronary heart disease. 
This finding is of major importance, as it convincingly 
shows that populations might benefit from reduction of 
NO2 concentrations to levels substantially lower than the 
current EU limit and WHO guideline value.
No long-term standards or guidelines exist for black 
carbon, which is used as an indicator for primary 
combustion particles. The literature is scarce for black 
carbon, but in line with our findings, a number of 
studies have indicated a positive association with 
incidence of stroke or coronary heart disease (or 
both).8,19–21,23 Similar to NO2, black carbon was only 
moderately correlated with PM2·5 in most of our cohorts 
and the associations with black carbon remained robust 
when adjusted for PM2·5. Black carbon and NO2 were, 
however, strongly correlated within most cohorts, 
resulting in substantially widened 95% CIs in two-
pollutant models, which limits interpretation of our 
results. Nevertheless, for stroke and coronary heart 
disease incident events, the NO2 association remained 
while the HR for black carbon was shifted to less than 1 
for both outcomes, potentially indicating a more robust 
association for NO2 and, possibly to some extent, a 
direct effect of NO2. This finding might also reflect 
differential measurement error since NO2 models were 
based on more sites than the models for black carbon. 
However, the performance of the NO2 model was only 
slightly better than the black carbon model (5-fold 
cross-validation R² values of 58% for NO2 and 51% for 
black carbon).
We did not observe positive associations between warm-
season O3 and incidence of stroke or coronary heart 
disease as reported previously.3,9,11 Single pollutant HR 
estimates for O3 were inverse for both outcomes, but 
shifted to positive (stroke) or attenuated towards 1 
(coronary heart disease) after adjustment for NO2. Possible 
reasons might be the small exposure contrast for O3 in our 
study regions with most of the estimated concentrations 
ranging between 70 µg/m³ and 80 µg/m³, whereas ranges 
of 32–128 µg/m³ were observed in Canada9 and 
60–120 µg/m³ in the USA.3 Additionally, the correlation of 
O3 with PM2·5 was low but positive in both North American 
studies (Pearson’s r=0·2 in Canada and r=0·24 in the 
USA), while we observed mostly moderate negative 
correlations with PM2·5 (Spearman’s r values 0·18 to –0·62) 
and highly negative correlations with NO2 (–0·15 to –0·85). 
Therefore, we do not consider our study to be informative 
on the health effects of long-term O3 exposure.
Our study has several limitations. Air pollution 
concentrations were estimated for the year 2010 and 
assigned to the baseline addresses of the participants. 
Because residential histories were not available for all 
participants, additional exposure misclassification might 
have been introduced. However, sensitivity analyses with 
back-extrapolated and time-varying exposures indicated 
mostly similar associations to those in the main analysis. 
Exposures were assessed on a 100 m grid scale, which is 
small compared with other large-scale air pollution 
studies in Canada and the USA. For NO2 and black 
carbon, the 100 m scale cannot fully characterise local 
variation because the pollutants are highly variable. 
However, a study across the Netherlands showed high 
correlations between our ELAPSE exposure model 
predictions for NO2 with a national LUR model (Pearson’s 
r=0·83) and a dispersion model (r=0·79), both of which 
used exact addresses and models based on the monitoring 
locations.40 Besides area-level socioeconomic status and 
transportation noise, we did not consider additional 
contextual factors such as greenness or walkability of 
areas, which might have been related to both air pollution 
and cardiovascular disease incidence. Furthermore, we 
cannot exclude differences in the accuracy of diagnosis 
for incident stroke and coronary heart disease across the 
cohorts, considering that hospital discharges, mortality 
registries, and medical records were used to confirm the 
diagnosis. To adjust for these potential inconsistencies, 
we applied Cox models stratified by subcohort, thus 
allowing the baseline hazard to vary by subcohort. 
Focusing on low-level air pollution, we did not consider 
subclassifications of stroke due to concerns over study 
power and differences in diagnostic procedures both 
with time and across cohorts. Strengths of this study 
include the large sample size, pooling and harmonisation 
of cohort data and subsequent analysis, and availability 
of a broad range of potential confounders. Furthermore, 
the centrally developed European-wide exposure sur-
faces ensured comparable estimates across cohorts. In 
addition, data on road traffic noise was available for most 
cohorts, allowing additional adjustment for this 
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For the ELAPSE protocol see 
http://www.elapseproject.eu/
important environmental risk factor for cardiovascular 
disease. With this robust study design, we were able to 
examine concentration-response functions at values 
lower than current regulatory limits.
In conclusion, at concentrations much lower than the 
current EU annual mean limits, long-term air pollution 
exposure was associated with incidence of stroke and 
coronary heart disease in this multicentre European 
study.
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